Toth Financial Advisory’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.09K | Hold |
1,000
| – | – | ﹤0.01% | 506 |
|
|
2025
Q1 | $8.38K | Hold |
1,000
| – | – | ﹤0.01% | 470 |
|
|
2024
Q4 | $7.92K | Hold |
1,000
| – | – | ﹤0.01% | 470 |
|
|
2024
Q3 | $8.32K | Hold |
1,000
| – | – | ﹤0.01% | 464 |
|
|
2024
Q2 | $6.35K | Hold |
1,000
| – | – | ﹤0.01% | 503 |
|
|
2024
Q1 | $6.06K | Hold |
1,000
| – | – | ﹤0.01% | 497 |
|
|
2023
Q4 | $6.07K | Hold |
1,000
| – | – | ﹤0.01% | 506 |
|
|
2023
Q3 | $4.22K | Hold |
1,000
| – | – | ﹤0.01% | 548 |
|
|
2023
Q2 | $3.1K | Hold |
1,000
| – | – | ﹤0.01% | 594 |
|
|
2023
Q1 | $1.39K | Hold |
1,000
| – | – | ﹤0.01% | 713 |
|
|
2022
Q4 | $1.99K | Hold |
1,000
| – | – | ﹤0.01% | 588 |
|
|
2022
Q3 | $2K | Hold |
1,000
| – | – | ﹤0.01% | 615 |
|
|
2022
Q2 | $3K | Hold |
1,000
| – | – | ﹤0.01% | 537 |
|
|
2022
Q1 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 549 |
|
|
2021
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 554 |
|
|
2021
Q3 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 551 |
|
|
2021
Q2 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 497 |
|
|
2021
Q1 | $7K | Hold |
1,000
| – | – | ﹤0.01% | 481 |
|
|
2020
Q4 | $5K | Hold |
1,000
| – | – | ﹤0.01% | 451 |
|
|
2020
Q3 | $4K | Hold |
1,000
| – | – | ﹤0.01% | 431 |
|
|
2020
Q2 | $5K | Buy |
+1,000
| New | +$5K | ﹤0.01% | 395 |
|